Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24584918 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines
Condition: Rheumatoid Arthritis
Interventions: Other: Placebo;   Biological: Certolizumab pegol

Indicates status has not been verified in more than two years